A. M. Dhople

410 total citations
43 papers, 313 citations indexed

About

A. M. Dhople is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, A. M. Dhople has authored 43 papers receiving a total of 313 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Infectious Diseases, 27 papers in Epidemiology and 14 papers in Molecular Biology. Recurrent topics in A. M. Dhople's work include Mycobacterium research and diagnosis (27 papers), Leprosy Research and Treatment (27 papers) and Tuberculosis Research and Epidemiology (12 papers). A. M. Dhople is often cited by papers focused on Mycobacterium research and diagnosis (27 papers), Leprosy Research and Treatment (27 papers) and Tuberculosis Research and Epidemiology (12 papers). A. M. Dhople collaborates with scholars based in United States, Japan and Germany. A. M. Dhople's co-authors include John H. Hanks, Lisa Koodie, Kensuke Namba, Kenji Namba, Linda J. Osborne, Frank M. Collins, Eleanor E. Storrs, Susan R. Watson, Norman Morrison and Manda Sathish and has published in prestigious journals such as Science, Antimicrobial Agents and Chemotherapy and Infection and Immunity.

In The Last Decade

A. M. Dhople

41 papers receiving 282 citations

Peers

A. M. Dhople

EPIDE

SURGE

Mamadou Daffé France

Gaby Silve France

Anne Dietz Germany

Lionel Horgen Guadeloupe

Isabelle Poncin France

Joachim Stephan Germany

Blair R. G. Gordon Canada

H L David France

Marcia L. Sokol-Anderson United States

H Blöch Switzerland

Mamadou Daffé France

A. M. Dhople

189 ×1.0

199 ×1.2

EPIDE

176 ×2.2

25 ×0.6

SURGE

35 ×1.1

Citations per year, relative to A. M. Dhople A. M. Dhople (= 1×) peers Mamadou Daffé

Countries citing papers authored by A. M. Dhople

Since Specialization

Citations

This map shows the geographic impact of A. M. Dhople's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. M. Dhople with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. M. Dhople more than expected).

Fields of papers citing papers by A. M. Dhople

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. M. Dhople. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. M. Dhople. The network helps show where A. M. Dhople may publish in the future.

Co-authorship network of co-authors of A. M. Dhople

This figure shows the co-authorship network connecting the top 25 collaborators of A. M. Dhople. A scholar is included among the top collaborators of A. M. Dhople based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. M. Dhople. A. M. Dhople is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dhople, A. M.. (2011). In vivo Susceptibility of Mycobacterium ulcerans to KRM-1648, a New Benzoxazinorifamycin, in Comparison with Rifampicin. Arzneimittelforschung. 51(6). 501–505. 2 indexed citations

Dhople, A. M. & Kenji Namba. (2003). In-vitro activity of sitafloxacin (DU-6859a), either singly or in combination with rifampin analogs, against Mycobacterium leprae. Journal of Infection and Chemotherapy. 9(1). 12–15. 5 indexed citations

Dhople, A. M. & Kensuke Namba. (2003). Activities of Sitafloxacin (DU-6859a), Either Singly or in Combination with Rifampin, AgainstMycobacterium ulceransInfection in Mice. Journal of Chemotherapy. 15(1). 47–52. 12 indexed citations

Dhople, A. M. & Kenji Namba. (2003). In vivo susceptibility of Mycobacterium leprae to sitafloxacin (DU-6859a), either singly or in combination with rifampicin analogues. International Journal of Antimicrobial Agents. 21(3). 251–255. 5 indexed citations

Dhople, A. M.. (2002). In vivo activity of epiroprim, a dihydrofolate reductase inhibitor, singly and in combination with dapsone, against Mycobacterium leprae. International Journal of Antimicrobial Agents. 19(1). 71–74. 12 indexed citations

Dhople, A. M.. (2002). In vitro activity of sitafloxacin (DU-6859a) alone, or in combination with rifampicin, against Mycobacterium ulcerans. Journal of Antimicrobial Chemotherapy. 50(5). 727–729. 13 indexed citations

Dhople, A. M.. (2001). In vitro activity of KRM-1648, either singly or in combination with ofloxacin, against Mycobacterium ulcerans. International Journal of Antimicrobial Agents. 17(1). 57–61. 9 indexed citations

Dhople, A. M.. (2001). Antimicrobial activities of dihydrofolate reductase inhibitors, used singly or in combination with dapsone, against Mycobacterium ulcerans. Journal of Antimicrobial Chemotherapy. 47(1). 93–96. 14 indexed citations

Dhople, A. M., et al.. (2000). ATP content of Mycobacterium tuberculosis grown in vivo and in vitro.. PubMed. 101(399). 81–8. 3 indexed citations

10.

Dhople, A. M.. (1999). In vitro activity of epiroprim, a dihydrofolate reductase inhibitor, singly and in combination with brodimoprim and dapsone, against Mycobacterium leprae. International Journal of Antimicrobial Agents. 12(4). 319–323. 14 indexed citations

11.

Dhople, A. M., et al.. (1998). The activity of rifabutin against Mycobacterium leprae in armadillos. International Journal of Antimicrobial Agents. 9(3). 169–173. 5 indexed citations

12.

Dhople, A. M., et al.. (1995). In vitro activities of 2,2′-bipyridyl analogues against Mycobacterium avium and M. tuberculosis. Tubercle and Lung Disease. 76(2). 136–140. 9 indexed citations

13.

Dhople, A. M., et al.. (1993). In-vitro activity of three new fluoroquinolones and synergy with ansamycins against Mycobacterium leprae. Journal of Antimicrobial Chemotherapy. 32(3). 445–451. 10 indexed citations

14.

Dhople, A. M., et al.. (1991). Factors Influencing the in vitro Growth of Mycobacterium leprae: Effect of Oxygen. Microbiology and Immunology. 35(7). 507–514. 3 indexed citations

15.

Brandt, Fredric S, et al.. (1990). The pathology of the eye in armadillos experimentally infected withMycobacterium leprae. Leprosy Review. 61(2). 112–31. 1 indexed citations

16.

Dhople, A. M., et al.. (1988). Limited in vitro multiplication of Mycobacterium leprae. Annales de l Institut Pasteur Microbiologie. 139(2). 213–223. 13 indexed citations

17.

Collins, Frank M., Norman Morrison, A. M. Dhople, & Susan R. Watson. (1980). Microscopic counts carried out on Mycobacterium leprae and M. tuberculosis suspensions. A comparison of three staining procedures.. PubMed. 48(4). 402–7. 7 indexed citations

18.

Dhople, A. M. & John H. Hanks. (1977). In Vitro Growth of Mycobacterium lepraemurium , an Obligate Intracellular Microbe. Science. 197(4301). 379–381. 16 indexed citations

19.

Dhople, A. M.. (1971). Muscle damage in leprosy.. PubMed. 38(3). 282–5. 1 indexed citations

20.

Dhople, A. M., et al.. (1968). Liver function tests in leprosy.. The Indian Journal of Medical Research. 56(10). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact